Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Enables researchers to generate more data in less time to support both preclinical and clinical studies Uppsala, Sweden, 27 January 2021: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Bioaffy™ 4000 CD for immunoassay applications in biotherapeutic workflows. The new... Read more

Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2

ANN ARBOR, Mich., Jan. 27, 2021 /PRNewswire/ — Swift Biosciences of Ann Arbor, MI  has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization. A pioneer in the development of DNA and RNA library... Read more

Clear Labs Launches Groundbreaking Solution for Enhanced Screening and Genomic Surveillance of SARS-CoV-2 and its Mutations

Leader in Next-Generation Sequencing Automation Workflow Solutions Delivers First Turn-key Solution for Whole Genome Sequencing (WGS) of COVID-19 SAN CARLOS, CALIF. (PRWEB) JANUARY 27, 2021 As the COVID-19 virus mutates, so does this growing list of variants, including B.1.1.7., B.1.351 and L452R. These variants, as well as future mutations, can now be identified in real-time by... Read more

Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020... Read more

BD Names CEO Tom Polen as Chairman of the Board

Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who... Read more

SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher Scientific to Help Reduce the Cost of NGS Library Prep

Initiative to promote the benefit of using Thermo Fisher Scientific’s library prep kits with SPT Labtech’s instruments to help reduce reagent and material requirements for high-throughput genome sequencing  To download this image, please click here.  Cambridge, UK – January 26 2021 – The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies,... Read more

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings extend the... Read more

LGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing

LGC has expanded its innovative portfolio of SARS-CoV-2 quality solutions with the release of AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid reference material. The product is designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics.  It serves as an ideal research tool for assay developers as well as a complete quality solution for clinical laboratories... Read more

PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery

New offerings join PerkinElmer’s leading GPCR Portfolio across characterization and screening assays, screening libraries and workflow optimization WALTHAM, Mass. – January 26, 2021 –PerkinElmer, a global leader committed to innovating for a healthier world, today announced the addition of new assay kits to help further GPCR      (G Protein-Coupled Receptor) therapeutic discovery. The new PerkinElmer offerings... Read more